- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 27th, 2006
A small band of researchers scattered around the country from East Tennessee State University to Harvard's Brigham and Women's Hospital are about to test a new, nanotech approach to heading off a potential bird flu pandemic.
The scientists are developing liposomes, fatty globules used as a tiny drug delivery device, which contain a mix of antioxidants and anti-viral drugs. The researchers believe that these liposomes, which can be reduced to a size as small as 25 to 50 nanometers, can cripple the lethal chain reaction that allows a virus to replicate, saving the patient.
|Related News Press|
'Material universe' yields surprising new particle November 28th, 2015
New 'self-healing' gel makes electronics more flexible November 25th, 2015
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
IU chemists craft molecule that self-assembles into flower-shaped crystalline patterns:'Tricarb' research laid foundation for university's new $1.2 million materials science grant from National Science Foundation December 1st, 2015